Oxford buys U.K. office, continues rapid life sciences growth
Oxford Properties Group has made its first life sciences acquisition in the United Kingdom as part of its plan to build a multi-billion-dollar portfolio in the sector. The Toronto-based global investor, asset manager and developer paid $77.2 million Cdn to